Equities

Glenmark Life Sciences Ltd

Glenmark Life Sciences Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,099.25
  • Today's Change9.25 / 0.85%
  • Shares traded88.60k
  • 1 Year change+73.44%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 09:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue22,83221,61221,232
OPERATING EXPENSES
Cost of revenue total10,02010,14110,429
Selling, general and admin. expenses, total5,7614,7874,635
Depreciation/amortization535421379
Unusual expense(income)------
Other operating expenses, total296256(3.19)
Total operating expense16,61115,60515,440
Operating income6,2216,0085,792
Other, net(0.01)1.36(0.72)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes6,3136,2865,649
Provision for income taxes1,6041,6161,462
Net income after taxes4,7094,6704,187
Minority interest------
Net income before extra. Items4,7094,6704,187
Total extraordinary items------
Net income4,7094,6704,187
Inc.avail. to common excl. extra. Items4,7094,6704,187
Inc.avail. to common incl. extra. Items4,7094,6704,187
EPS RECONCILIATION
Basic/primary weighted average shares123123118
Basic/primary eps excl. extra items383836
Basic/primary eps incl. extra items383836
Dilution adjustment------
Diluted weighted average shares123123118
Diluted eps excl. extra items383836
Diluted eps incl. extra items383836
COMMON STOCK DIVIDENDS
DPS - common stock primary issue232121
Gross dividend - common stock2,7572,5730
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental155.15279
SUPPLEMENTAL INCOME
Depreciation, supplemental498406369
Total special items7.045.587.43
NORMALISED INCOME
Normalized income before taxes6,3206,2925,657
Effect of special items on income taxes1.791.431.92
Income tax excluding impact of special items1,6061,6181,464
Normalized income after tax4,7144,6744,193
Normalized income avail. to common4,7144,6744,193
Basic normalized EPS383836
Diluted normalized EPS383836
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.